Neoadjuvant Chemotherapy for Resectable Non–Small-Cell Lung Cancer
September 14, 2009ByJhanelle E. Gray, MD|Eric Sommers, MD|Miguel Alvelo-rivera, MD|Lary Robinson, MD|Gerold Bepler, MD, PhD
Lung cancer is the most common cancer diagnosed in men and women in the United States, and is the leading cause of cancer death.Over 160,000 individuals died as a result of lung cancer in 2008. This number amounted to more than the number of deaths from colon, breast, and prostate cancers combined. The majority of lung cancer cases are non–small-cell lung cancer (NSCLC), and the poor outcomes are attributed to the high rate of metastases associated with this disease.